InVivo Therapeutics Holdings Corp. Stock
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 USD | 0.00% | -3.54% | -50.68% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -10M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M | Net cash position 2022 | 15.4M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | 6 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1 week | -3.54% | ||
Current month | +63.64% | ||
1 month | +38.46% | ||
3 months | -46.48% | ||
6 months | -61.76% | ||
Current year | -50.68% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.36 | 0.00% | 1 357 |
24-04-23 | 0.36 | 0.00% | 388 |
24-04-22 | 0.36 | 0.00% | 2,882 |
24-04-19 | 0.36 | -2.44% | 6,429 |
24-04-18 | 0.369 | -1.13% | 13,717 |
Delayed Quote OTC Markets, April 24, 2024 at 03:53 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-50.68% | 1.12M | |
+8.78% | 219B | |
+8.24% | 187B | |
+11.16% | 134B | |
+26.12% | 101B | |
+0.30% | 62.27B | |
+16.21% | 52.82B | |
-1.63% | 47.49B | |
-1.11% | 40.79B | |
+12.16% | 39.35B |
- Stock Market
- Equities
- NVIV Stock